![Page 1: Immunization Safety Review: Vaccines and Autism](https://reader035.vdocuments.us/reader035/viewer/2022062518/568145e9550346895db2e9a8/html5/thumbnails/1.jpg)
Immunization Safety Review:Vaccines and Autism
Marie McCormickChair, Immunization Safety Review Committee
Presentation to NVAC June 2004
![Page 2: Immunization Safety Review: Vaccines and Autism](https://reader035.vdocuments.us/reader035/viewer/2022062518/568145e9550346895db2e9a8/html5/thumbnails/2.jpg)
Issue Under Review
Hypothesized association between vaccines and autism, specifically:
• MMR vaccine and autism • Thimerosal-containing vaccines and autism
• The committee did not focus on other neurodevelopmental disorders
![Page 3: Immunization Safety Review: Vaccines and Autism](https://reader035.vdocuments.us/reader035/viewer/2022062518/568145e9550346895db2e9a8/html5/thumbnails/3.jpg)
Why the committee focused on this topic
• Requested by the Interagency Vaccine Group to reexamine this issue in its eighth and final report. – The committee issued two previous reports in 2001
examining MMR and autism and thimerosal-containing vaccines and neurodevelopmental disorders.
• Updated statement from the committee was warranted because significant new data have emerged, and because the topic remains of such considerable controversy.
![Page 4: Immunization Safety Review: Vaccines and Autism](https://reader035.vdocuments.us/reader035/viewer/2022062518/568145e9550346895db2e9a8/html5/thumbnails/4.jpg)
Scientific Assessment: Causality Conclusions
The evidence favors rejection of a causal relation between both MMR vaccine and thimerosal-containing vaccines and autism.
![Page 5: Immunization Safety Review: Vaccines and Autism](https://reader035.vdocuments.us/reader035/viewer/2022062518/568145e9550346895db2e9a8/html5/thumbnails/5.jpg)
Scientific Assessment: Causality Conclusions
Evidence for MMR and autism finding: • 14 large, well-designed epidemiological studies
consistently showed no association between the MMR vaccine and autism.
This finding is consistent with 2001 report on MMR and autism
![Page 6: Immunization Safety Review: Vaccines and Autism](https://reader035.vdocuments.us/reader035/viewer/2022062518/568145e9550346895db2e9a8/html5/thumbnails/6.jpg)
Scientific Assessment: Causality Conclusions
Evidence for thimerosal and autism finding: • 5 large, well-designed epidemiological studies in different countries
provided significant evidence of no association between TCVs and autism.
2001 IOM report concluded evidence was inadequate to accept or reject relationship between TCVs and NDDs. Why different now? – Only one unpublished epi study available then. Significantly more
research available now.– That report focused on broader set of neurodevelopmental outcomes.
A potential biological mechanism exists for those outcomes by way of analogy with methyl mercury, but not for autism
![Page 7: Immunization Safety Review: Vaccines and Autism](https://reader035.vdocuments.us/reader035/viewer/2022062518/568145e9550346895db2e9a8/html5/thumbnails/7.jpg)
Scientific Assessment:Biological Mechanisms
Potential biological mechanisms put forth as possible explanations for how vaccines might cause autism:
– The release of chemicals into the brain due to disruption of intestinal function by the MMR vaccine
– Triggering of abnormalities in the immune system that are indicative of vaccine-induced damage to the CNS
– Increased accumulation of and decreased excretion of mercury from the brains of a subgroup of children
– The effects of thimerosal on a variety of biochemical pathways
![Page 8: Immunization Safety Review: Vaccines and Autism](https://reader035.vdocuments.us/reader035/viewer/2022062518/568145e9550346895db2e9a8/html5/thumbnails/8.jpg)
Scientific Assessment:Biological Mechanisms
• Evidence comes from in vitro experimental systems, clinical observations, and analogies between rodent behavior and human behavior.
• While the laboratory observations of the toxic effects of mercury are important, these observations do not explain how specific exposures in a rapidly developing infant affect certain tissues but not others where these mechanisms are also active.
• Laboratory studies also have not shown how these effects lead to autism.
![Page 9: Immunization Safety Review: Vaccines and Autism](https://reader035.vdocuments.us/reader035/viewer/2022062518/568145e9550346895db2e9a8/html5/thumbnails/9.jpg)
Scientific Assessment:Biological Mechanisms Conclusion
In the absence of experimental or human evidence that either the MMR vaccine or vaccines containing thimerosal affect metabolic, developmental, immune, or other physiological or molecular mechanisms that are causally related to the development of autism, the committee concludes that the hypotheses generated to date are theoretical only.
![Page 10: Immunization Safety Review: Vaccines and Autism](https://reader035.vdocuments.us/reader035/viewer/2022062518/568145e9550346895db2e9a8/html5/thumbnails/10.jpg)
Significance Assessment
The committee concludes that because autism can be such a devastating condition, any speculation that links vaccine and autism means that this is a significant issue.
![Page 11: Immunization Safety Review: Vaccines and Autism](https://reader035.vdocuments.us/reader035/viewer/2022062518/568145e9550346895db2e9a8/html5/thumbnails/11.jpg)
Recommendations for Public Health Response
The committee recommends a public health response that fully supports an array of vaccine safety activities.
The committee recommends that available for funding for autism research be channeled to the most promising areas.
![Page 12: Immunization Safety Review: Vaccines and Autism](https://reader035.vdocuments.us/reader035/viewer/2022062518/568145e9550346895db2e9a8/html5/thumbnails/12.jpg)
Recommendations for Public Health Response:
Policy Review
• No policy review of the licensure of the MMR vaccine or thimerosal-containing vaccines and or of current schedule and recommendations for administration of those vaccines.
![Page 13: Immunization Safety Review: Vaccines and Autism](https://reader035.vdocuments.us/reader035/viewer/2022062518/568145e9550346895db2e9a8/html5/thumbnails/13.jpg)
Recommendations for Surveillance and Epidemiological Research
• Use standard and accepted case definitions and assessment protocols for ASD
• Conduct clinical and epidemiological studies of sufficient rigor to identify risk factors and biological markers of ASD
• Strengthen surveillance of adverse events – e.g., standardize case definitions of adverse events; establish
guidelines for use of VAERS; continue use of large linked databases and other tools; further develop of CISA.
![Page 14: Immunization Safety Review: Vaccines and Autism](https://reader035.vdocuments.us/reader035/viewer/2022062518/568145e9550346895db2e9a8/html5/thumbnails/14.jpg)
Recommendations for Surveillance and Epidemiological Research (cont.)
• Conduct surveillance of ASD as exposure to thimerosal declines
• Increase efforts to quantify level of prenatal and postnatal exposure to thimerosal and other forms of mercury in infants, children, and pregnant women
![Page 15: Immunization Safety Review: Vaccines and Autism](https://reader035.vdocuments.us/reader035/viewer/2022062518/568145e9550346895db2e9a8/html5/thumbnails/15.jpg)
Recommendations for Clinical Studies
• Because chelation therapy has potentially serious risks, the committee recommends that it be used only in carefully-controlled research settings with appropriate oversight by Institutional Review Boards protecting the interests of children who participate.
![Page 16: Immunization Safety Review: Vaccines and Autism](https://reader035.vdocuments.us/reader035/viewer/2022062518/568145e9550346895db2e9a8/html5/thumbnails/16.jpg)
Recommendations for Communication
• Develop programs to increase public participation in vaccine safety research and policy decisions AND to enhance the skills and willingness of scientists and government officials to engage in constructive dialogue with the public about research findings and their implications for policy development.
![Page 17: Immunization Safety Review: Vaccines and Autism](https://reader035.vdocuments.us/reader035/viewer/2022062518/568145e9550346895db2e9a8/html5/thumbnails/17.jpg)
Contact Information
• Phone: (202) 334-1342
• Email: [email protected]
• Website: www.iom.edu/imsafety